Controversies
Controversies tied to this brand in public sources. A listing is not a finding of fault.
Back to profile4 entries
2017
FDA finding on belladonna content
The FDA stated that testing had found inconsistent and sometimes excessive levels of belladonna in the teething product.
2016
Dispute over reported adverse events and U.S. withdrawal
The FDA cited reports involving ten child deaths and about 400 adverse events associated with Hyland's Teething Tablets. Hyland's disputed the claims as unsubstantiated and announced that it would stop selling the product in the United States.
2013
FDA concerns over product labeling and marketing
An FDA review found numerous Hyland's products that the agency considered misbranded under the Federal Food, Drug, and Cosmetic Act, including products marketed for conditions that could require medical consultation.
2010
FDA warning and recall of teething products
The FDA warned consumers about Hyland's teething products because of concerns about belladonna toxicity and the lack of child-resistant caps. Hyland's voluntarily recalled the product in the United States and Canada.